Justin is a patent attorney in our Life Sciences & Chemistry group, primarily working on drafting and prosecuting patent applications in the UK, Europe and around the world, and devising appropriate patenting strategies to protect his clients’ technologies to the greatest extent possible.
In addition, Justin has handled several oppositions and appeals before the European Patent Office and has been involved in several due diligence projects, some of which in relation to stock market listings and potential acquisitions.
More broadly, Justin has experience in biochemistry, immunology and pharmacology. Some of the specific areas he has worked on with clients include: new active pharmaceutical ingredients; formulations of pharmaceuticals; drug delivery systems; screening and diagnostic methods using genetic and/or protein markers; therapeutic antibodies; vaccines; RNA therapeutics; gene therapies; therapeutic T-cells; diagnostic kits; bacteria and methods for genetically engineering bacteria, and biofuels. Justin also has experience in Supplementary Protection Certificates (SPCs).
Working with a range of different clients, Justin is comfortable adapting and tailoring his advice to suit a variety of needs. He works with a number of academic institutions, both in the UK and Europe, small to medium size companies and a number of large multinational organisations.
Education/Alumni: MBiochem, CPA, EPA
